Authors:
PURI A
HUG P
JERNIGAN K
BARCHI J
KIM HY
HAMILTON J
WIELS J
MURRAY GJ
BRADY RO
BLUMENTHAL R
Citation: A. Puri et al., THE NEUTRAL GLYCOSPHINGOLIPID GLOBOTRIAOSYLCERAMIDE PROMOTES FUSION MEDIATED BY A CD4-DEPENDENT CXCR4-UTILIZING HIV TYPE-1 ENVELOPE GLYCOPROTEIN, Proceedings of the National Academy of Sciences of the United Statesof America, 95(24), 1998, pp. 14435-14440
Authors:
SCHIFFMANN R
HEYES MP
AERTS JM
DAMBROSIA JM
PATTERSON MC
DEGRABA T
PARKER CC
ZIRZOW GC
OLIVER K
TEDESCHI G
BRADY RO
BARTON NW
NAGINENI C
KANESKI CR
MURRAY GJ
HIGGINS JJ
TOURNAY A
BANERJEE TK
KREPS C
SCOTT LJC
MCKEE MA
CRUTCHFIELD K
FREI K
Citation: R. Schiffmann et al., PROSPECTIVE-STUDY OF NEUROLOGICAL RESPONSES TO TREATMENT WITH MACROPHAGE-TARGETED GLUCOCEREBROSIDASE IN PATIENTS WITH TYPE-3 GAUCHERS-DISEASE, Annals of neurology, 42(4), 1997, pp. 613-621
Authors:
BRADY RO
MURRAY GJ
OLIVER KL
LEITMAN SF
SNELLER MC
FLEISHER TA
BARTON NW
Citation: Ro. Brady et al., MANAGEMENT OF NEUTRALIZING ANTIBODY TO CEREDASE IN A PATIENT WITH TYPE-3 GAUCHER-DISEASE, Pediatrics, 100(6), 1997, pp. 111-114
Authors:
OHSHIMA T
MURRAY GJ
SWAIM WD
LONGENECKER G
QUIRK JM
CARDARELLI CO
SUGIMOTO Y
PASTAN I
GOTTESMAN MM
BRADY RO
KULKARNI AB
Citation: T. Ohshima et al., ALPHA-GALACTOSIDASE A DEFICIENT MICE - A MODEL OF FABRY DISEASE, Proceedings of the National Academy of Sciences of the United Statesof America, 94(6), 1997, pp. 2540-2544
Authors:
MEDIN JA
TUDOR M
SIMOVITCH R
QUIRK JM
JACOBSON S
MURRAY GJ
BRADY RO
Citation: Ja. Medin et al., GENE-THERAPY FOR FABRY DISEASE - EXPRESSION, SECRETION AND UPTAKE OF ALPHA-GALACTOSIDASE-A (ALPHA-GAL-A) DRIVEN BY A HIGH-TITER RECOMBINANTRETROVIRAL, The FASEB journal, 10(6), 1996, pp. 885-885
Authors:
MCCABE ERB
FINE BA
GOLBUS MS
GREENHOUSE JB
MCGRATH GL
NEW M
OBRIEN WE
ROWLEY PT
SLY WS
SPENCE MA
STOCKMAN JA
WHYTE M
WILSON W
WOLF B
AERTS JMFG
BARRANGER JA
BARTON NW
BEUTLER E
BRADY RO
COX TM
EKSTEIN J
ENG CM
ERIKSON A
FINDLING DM
GARBER AM
GINNS EI
GRABOWSKI GA
HILL SC
HOLLACK CEM
KABACK MM
LEE RE
MANKIN HJ
MISTRY PK
MOSCICKI RA
MURRAY GJ
NATOWICZ M
PASTORES GM
MIRANDA MCS
SIDRANSKY E
WARE JE
WILLEMSEN R
ZAIZOV R
ZIMRAN A
BEITINS IZ
BERMAN RE
ELLIOTT JM
FERGUSON JH
HALL WH
MCKEON C
NITKIN RM
SCHLESINGER SL
SHERIDAN PH
WEEKS M
COWDRY RW
ALEXANDER DF
GORDEN P
HALL ZW
VAITUKAITIS JL
COLLINS FS
GROFT S
Citation: Erb. Mccabe et al., GAUCHER DISEASE - CURRENT ISSUES IN DIAGNOSIS AND TREATMENT, JAMA, the journal of the American Medical Association, 275(7), 1996, pp. 548-553
Authors:
MEDIN JA
TUDOR M
SIMOVITCH R
QUIRK JM
JACOBSON S
MURRAY GJ
BRADY RO
Citation: Ja. Medin et al., CORRECTION IN TRANS FOR FABRY DISEASE - EXPRESSION, SECRETION, AND UPTAKE OF ALPHA-GALACTOSIDASE-A IN PATIENT-DERIVED CELLS DRIVEN BY A HIGH-TITER RECOMBINANT RETROVIRAL VECTOR, Proceedings of the National Academy of Sciences of the United Statesof America, 93(15), 1996, pp. 7917-7922
Authors:
SUGIMOTO Y
AKSENTIJEVICH I
MURRAY GJ
BRADY RO
PASTAN I
GOTTESMAN MM
Citation: Y. Sugimoto et al., RETROVIRAL COEXPRESSION OF A MULTIDRUG-RESISTANCE GENE (MDR1) AND HUMAN ALPHA-GALACTOSIDASE-A FOR GENE-THERAPY OF FABRY DISEASE, Human gene therapy, 6(7), 1995, pp. 905-915
Citation: Gj. Murray et al., STUDIES ON THE TURNOVER OF EXOGENOUS MANNOSE-TERMINAL GLUCOCEREBROSIDASE IN RAT-LIVER LYSOSOMES, Journal of cellular biochemistry, 57(2), 1995, pp. 208-217
Citation: Gj. Murray et Fs. Jin, IMMUNOELECTRON MICROSCOPIC LOCALIZATION OF MANNOSE-TERMINAL GLUCOCEREBROSIDASE IN LYSOSOMES OF RAT-LIVER KUPFFER CELLS, The Journal of histochemistry and cytochemistry, 43(2), 1995, pp. 149-158
Citation: Ro. Brady et al., MODIFYING EXOGENOUS GLUCOCEREBROSIDASE FOR EFFECTIVE REPLACEMENT THERAPY IN GAUCHER DISEASE, Journal of inherited metabolic disease, 17(4), 1994, pp. 510-519